Kathrin Sutter Selected Research

Kathrin Sutter Research Topics

Disease

21	Infections 12/2022 - 11/2016
13	Virus Diseases (Viral Diseases) 02/2024 - 11/2016
7	Chronic Hepatitis B 01/2022 - 01/2017
4	Persistent Infection 12/2023 - 01/2018
4	COVID-19 01/2023 - 01/2020
4	HIV Infections (HIV Infection) 01/2020 - 12/2017
3	Neoplasms (Cancer) 10/2023 - 03/2019
2	Chronic Hepatitis (Chronic Active Hepatitis) 12/2023 - 07/2021
2	Human Influenza (Influenza) 01/2022 - 01/2019
2	Viremia 12/2019 - 01/2018
1	Hepatitis 12/2023
1	Hepatitis B 12/2023
1	Chronic Disease (Chronic Diseases) 10/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Inflammation (Inflammations) 10/2020
1	Measles 01/2019
1	Epstein-Barr Virus Infections 01/2019
1	Hypoxia (Hypoxemia) 12/2017
1	Retroviridae Infections (Infection, Retrovirus) 10/2017

Drug/Important Bio-Agent (IBA)

15	Antiviral Agents (Antivirals)IBA 02/2024 - 01/2017
12	Interferon Type IIBA 02/2024 - 11/2016
10	InterferonsIBA 10/2023 - 01/2018
3	VaccinesIBA 01/2021 - 01/2018
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2023 - 07/2021
2	Hepatitis B e AntigensIBA 12/2023 - 07/2021
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2019
2	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2017
2	Viral DNAIBA 12/2019 - 01/2018
2	AntibodiesIBA 03/2019 - 10/2017
1	AntigensIBA 12/2023
1	Transaminases (Aminotransferases)IBA 12/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	macrophage migration inhibitory factor receptorIBA 01/2023
1	Macrophage Migration-Inhibitory FactorsIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 12/2022
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Interferon-betaIBA 01/2021
1	Inactivated VaccinesIBA 01/2021
1	LipopolysaccharidesIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Antiviral Restriction FactorsIBA 01/2020
1	PerforinIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Viral AntigensIBA 01/2018
1	Oxygen (Dioxygen)IBA 12/2017
1	Fas Ligand Protein (Fas Ligand)IBA 10/2017
1	Interleukin-2 (IL2)IBA 11/2016
1	CytokinesIBA 11/2016
1	Interleukin-15 (Interleukin 15)IBA 11/2016
1	Interleukin-12 (IL 12)IBA 11/2016
1	Interleukin-18 (Interleukin 18)IBA 11/2016

Therapy/Procedure

6	Immunotherapy 10/2023 - 11/2016
5	Therapeutics 01/2022 - 01/2018
1	Art Therapy 10/2023
1	Duration of Therapy 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 12/2019
1	Subcutaneous Injections 01/2018
1	Aftercare (After-Treatment) 01/2017